https://orcid.org/0000-0002-0381-6174
References
- Dessinioti C, Stratigos AJ. Overview of guideline recommendations for the management of high-risk and advanced cutaneous squamous cell carcinoma. Acad Dermatol Venereol. 2022;36(S1):1–2.
- Stratigos AJ, Garbe C, Dessinioti C, European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC), et al. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: part 1. epidemiology, diagnostics and prevention. Eur J Cancer. 2020;128:60–82.
- Stratigos AJ, Garbe C, Dessinioti C, European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC), et al. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: part 2. treatment. Eur J Cancer. 2020;128:83–102.
- Kim JYS, Kozlow JH, Mittal B, Invited Reviewers, et al. Guidelines of care for the management of cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2018;78(3):560–578.
- Heppt MV, Steeb T, Berking C, et al. Comparison of guidelines for the management of patients with high-risk and advanced cutaneous squamous cell carcinoma – a systematic review. J Eur Acad Dermatol Venereol. 2019;33(S8):25–32.
- Stratigos A, Garbe C, Lebbe C, European Organization for Research and Treatment of Cancer (EORTC), et al. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: european consensus-based interdisciplinary guideline. Eur J Cancer. 2015;51(14):1989–2007.